Outstanding and Sustainable Development - Milkyway Was Awarded as “Dow Logistics S4TAR”
近日,密爾克衛董事長陳銀河受邀參加2023陶氏物流之星卓越實踐分享會,陶氏化學大中華區總裁朱成怡、陶氏化學全球物流總監Shenna Bennett、亞太區物流及客戶服務總監黃佳敏等出席會議。
The chairman of Milkyway - Andy CHEN was invited to the 2023 Dow S4TAR Leading Practice Symposium recently. The president of Dow Greater China - CherryZHU, the global logistics director of Dow-Shenna Bennett, and the Asian-Pacific region’s logistics and customer service director – Jessica HUANG also attended the meeting.
會上,密爾克衛榮獲陶氏年度物流之星-最佳貨代報關供應商,這一榮譽是公司長期致力于提供最優質服務,同時持續滿足客戶需求的重要成果。陳銀河董事長作為優秀供應商代表,分享了密爾克衛供應鏈可持續發展的解決方案,得到DOW高度認可。
Milkyway was awarded as the “Dow Logistics S4TAR of the Year - Best Freight Forwarding and Customs Declaration Supplier” at the meeting, which is an important achievement of Milkyway’s long-term commitment to provide the highest quality services while continuing to meet customer needs. As the representative of outstanding suppliers, Chairman Andy CHEN shared the solution for Milkyway supply chain’ sustainable development, which DOW highly recognized.
密爾克衛多年來兢兢業業、腳踏實地打造完善卓越管理和運營能力,同時在保持高效率、可靠性和時效性方面所取得了杰出成績。我們不僅提供卓越的化學品供應鏈服務,還積極踐行減碳政策,采用先進的技術和方案來保證全供應鏈服務健康可持續發展。能夠得到客戶認可,讓密爾克衛倍感珍惜;風雨同路,惟實勵新,我們會繼續懷揣理想、持續迭代,不畏困難,一路前行。
Milkyway has always been building excellent management and operation capacity with dedication and commitment over the past years, while maintaining remarkable performance in high efficiency, reliability and timeliness. We not only provide excellent chemical supply chain services, but are also actively engaged in carbon reduction policies, using advanced technologies and solutions to ensure the healthy and sustainable development of full supply chain service. Milkyway cherishes the recognition of customers and always pursues pragmatism and innovation. We will continue to carry out ideals and iterate and move forward despite all the difficulties.
免責聲明:市場有風險,選擇需謹慎!此文僅供參考,不作買賣依據。
關鍵詞:
版權與免責聲明:
1 本網注明“來源:×××”(非商業周刊網)的作品,均轉載自其它媒體,轉載目的在于傳遞更多信息,并不代表本網贊同其觀點和對其真實性負責,本網不承擔此類稿件侵權行為的連帶責任。
2 在本網的新聞頁面或BBS上進行跟帖或發表言論者,文責自負。
3 相關信息并未經過本網站證實,不對您構成任何投資建議,據此操作,風險自擔。
4 如涉及作品內容、版權等其它問題,請在30日內同本網聯系。